Exane Derivatives’s Citrix Systems Inc CTXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$21.9K Sell
225
-27
-11% -$2.69K 0.01% 360
2022
Q1
$25.4K Hold
252
0.01% 644
2021
Q4
$23.8K Sell
252
-125
-33% -$11.4K 0.01% 567
2021
Q3
$40.5K Sell
377
-63
-14% -$6.8K 0.01% 639
2021
Q2
$50K Sell
440
-12
-3% -$1.49K 0.01% 650
2021
Q1
$63.4K Sell
452
-5,336
-92% -$715K 0.02% 495
2020
Q4
$753K Sell
5,788
-222
-4% -$28.2K 0.22% 107
2020
Q3
$828K Buy
6,010
+3,214
+115% +$459K 0.24% 100
2020
Q2
$414K Buy
+2,796
New +$402K 0.11% 165
2017
Q1
Sell
-267
Closed -$19K 697
2016
Q4
$19K Hold
267
﹤0.01% 368
2016
Q3
$18.1K Hold
267
﹤0.01% 371
2016
Q2
$17.1K Buy
+267
New +$17.6K ﹤0.01% 342

Other funds holding CTXS

Exane Derivatives's CTXS Position: Q2 2022 in Review

Exane Derivatives reduced its Citrix Systems Inc (CTXS) stake by 11% in Q2 2022, selling an estimated $2.69K and leaving 225 shares worth $21.9K. The position accounts for 0.01% of the portfolio, ranked #360.

Exane Derivatives first reported a position in CTXS in Q2 2016 and has held it in 12 quarters since. The position peaked at $828K in Q3 2020. 571 funds tracked by Wall St. Rank hold CTXS as of Q2 2022.

  • Exane Derivatives held 225 shares of Citrix Systems Inc worth $21.9K as of Q2 2022.
  • Exane Derivatives sold 27 Citrix Systems Inc shares in Q2 2022, an estimated $2.69K.
  • Citrix Systems Inc made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #360 holding.
  • Exane Derivatives first reported a position in Citrix Systems Inc in Q2 2016 and has held it in 12 quarters since.
  • Exane Derivatives's Citrix Systems Inc position peaked at $828K in Q3 2020.
  • 571 funds tracked by Wall St. Rank held Citrix Systems Inc as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.